Urispas
Urispas

2.28
Used to address pain and inflammation, this generic medicine relaxes smooth muscle tissue. Eases bladder spasms and provides relief from urinary frequency and urgency.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Flavoxate hydrochloride
Reference Brand
Flavoxate
Product Origin
Generic Alternative
Reference Manufacturer
Indevus Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief, Bladder Health
Product Category
Urinary Antispasmodic
Pharmacological Class
Flavone Derivative
Clinical Indications
Manufacturer Description
Intended to relieve bladder muscle hypertonicity to support urinary comfort and target localized detrusor spasms.
Mechanism of Action
Exerts direct spasmolytic effects on the detrusor smooth muscle, blunting sensory cholinergic pathways to prevent bladder spasms.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
6–8 hours
Contraindications
Pyloric or duodenal obstruction, Obstructive uropathies, Gastrointestinal hemorrhage
Severe Adverse Events
Severe tachycardia — requires immediate medical attention, Severe hypersensitivity — requires immediate medical attention
Common Side Effects
Nausea, Dry mouth, Blurred vision
Uncommon Side Effects
Headache, Drowsiness, Constipation
Drug Interactions
Anticholinergics
Pregnancy Safety Warnings
TGA Category B: Safety verified in animal models. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for children over twelve years and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Urispas is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to buy Autoimmune Treatment Australia - Baricitinib JAK Inhibitor Rheumatoid